ArticlePharmaceutics2022

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin.

Fuyuki F Inagaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.